Ticker Launch
Sign inTry it free

SPAC · Merger completed

Bison Capital Acquisition Corp.

Business combination with Xynomic Pharmaceuticals, Inc.

Bison Capital Acquisition Corp. is a blank-check company (SPAC) that raised $52.5M in its initial public offering on Jun 21, 2017, listing on Nasdaq Capital Market. It completed its business combination with Xynomic Pharmaceuticals, Inc. on May 15, 2019; the combined company is Xynomic Pharmaceuticals Holdings, Inc. (XYN). Hunter Taubman Fischer & Li advised the SPAC and Graubard Miller advised the underwriters on the IPO.

Xynomic Pharmaceuticals is a clinical-stage biopharmaceutical company developing oncology therapeutics. It aims to develop and commercialize drugs for solid tumors and hematological malignancies to address unmet needs and improve cancer patients' life expectancy and prognosis.

Status
Merger completed
IPO date
Jun 21, 2017
IPO size
$52.5M
IPO exchange
Nasdaq Capital Market
Target
Xynomic Pharmaceuticals, Inc.
Announced
Sep 13, 2018
Closed
May 15, 2019
Combined company
Xynomic Pharmaceuticals Holdings, Inc. (XYN)
SPAC counsel (IPO)
Hunter Taubman Fischer & Li and Ogier
Underwriters' counsel (IPO)
Graubard Miller

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2019